HAVCR2 and ovarian cancer: Moreover, in line with our findings in samples from HGSOC patients, effector PD1+CD8+ T cells preferentially displayed a TIM3+PD1+CD8+ phenotype in the TMBHi ovarian cancer model (Fig. 6G).